Annual EBIT
-$9.65 M
+$8.89 M+47.97%
31 December 2023
Summary:
Cyclerion Therapeutics annual earnings before interest & taxes is currently -$9.65 million, with the most recent change of +$8.89 million (+47.97%) on 31 December 2023. During the last 3 years, it has risen by +$73.29 million (+88.37%). CYCN annual EBIT is now at all-time high.CYCN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.13 M
+$256.00 K+18.50%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly earnings before interest & taxes is currently -$1.13 million, with the most recent change of +$256.00 thousand (+18.50%) on 30 September 2024. Over the past year, it has increased by +$1.58 million (+58.39%). CYCN quarterly EBIT is now at all-time high.CYCN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$5.92 M
+$1.58 M+21.08%
30 September 2024
Summary:
Cyclerion Therapeutics TTM earnings before interest & taxes is currently -$5.92 million, with the most recent change of +$1.58 million (+21.08%) on 30 September 2024. Over the past year, it has increased by +$6.38 million (+51.85%). CYCN TTM EBIT is now at all-time high.CYCN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.0% | +58.4% | +51.9% |
| 3 y3 years | +88.4% | +90.0% | +90.0% |
| 5 y5 years | +91.6% | +96.0% | +95.4% |
CYCN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +88.4% | at high | +92.1% | at high | +90.0% |
| 5 y | 5 years | at high | +92.3% | at high | +96.0% | at high | +95.4% |
| alltime | all time | at high | +92.3% | at high | +97.0% | at high | +95.5% |
Cyclerion Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.13 M(-18.5%) | -$5.92 M(-21.1%) |
| June 2024 | - | -$1.38 M(-14.5%) | -$7.51 M(-6.0%) |
| Mar 2024 | - | -$1.62 M(-9.9%) | -$7.99 M(-17.2%) |
| Dec 2023 | -$9.65 M(-48.0%) | -$1.79 M(-33.8%) | -$9.65 M(-21.6%) |
| Sept 2023 | - | -$2.71 M(+45.4%) | -$12.31 M(-12.8%) |
| June 2023 | - | -$1.86 M(-43.1%) | -$14.11 M(-45.0%) |
| Mar 2023 | - | -$3.27 M(-26.5%) | -$25.68 M(-27.4%) |
| Dec 2022 | -$18.54 M(-65.9%) | -$4.46 M(-1.4%) | -$35.39 M(-21.8%) |
| Sept 2022 | - | -$4.52 M(-66.4%) | -$45.27 M(-13.0%) |
| June 2022 | - | -$13.43 M(+3.5%) | -$52.04 M(-3.5%) |
| Mar 2022 | - | -$12.98 M(-9.4%) | -$53.90 M(-0.8%) |
| Dec 2021 | -$54.31 M | -$14.34 M(+27.1%) | -$54.31 M(-8.3%) |
| Sept 2021 | - | -$11.29 M(-26.2%) | -$59.20 M(-14.5%) |
| June 2021 | - | -$15.29 M(+14.2%) | -$69.25 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$13.39 M(-30.3%) | -$73.63 M(-11.2%) |
| Dec 2020 | -$82.93 M(-33.7%) | -$19.22 M(-9.9%) | -$82.93 M(-8.2%) |
| Sept 2020 | - | -$21.34 M(+8.5%) | -$90.30 M(-6.9%) |
| June 2020 | - | -$19.67 M(-13.3%) | -$96.98 M(-12.1%) |
| Mar 2020 | - | -$22.70 M(-14.6%) | -$110.36 M(-11.7%) |
| Dec 2019 | -$125.04 M(+8.5%) | -$26.59 M(-5.1%) | -$125.04 M(-3.3%) |
| Sept 2019 | - | -$28.02 M(-15.2%) | -$129.35 M(-1.0%) |
| June 2019 | - | -$33.05 M(-11.6%) | -$130.62 M(+2.6%) |
| Mar 2019 | - | -$37.38 M(+21.0%) | -$127.35 M(+10.5%) |
| Dec 2018 | -$115.25 M(+22.7%) | -$30.90 M(+5.5%) | -$115.25 M(+36.6%) |
| Sept 2018 | - | -$29.29 M(-1.7%) | -$84.35 M(+53.2%) |
| June 2018 | - | -$29.78 M(+17.8%) | -$55.06 M(+117.8%) |
| Mar 2018 | - | -$25.28 M | -$25.28 M |
| Dec 2017 | -$93.92 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual EBIT year-on-year change?
- What is Cyclerion Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly EBIT year-on-year change?
- What is Cyclerion Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM EBIT year-on-year change?
What is Cyclerion Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CYCN is -$9.65 M
What is the all time high annual EBIT for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual earnings before interest & taxes is -$9.65 M
What is Cyclerion Therapeutics annual EBIT year-on-year change?
Over the past year, CYCN annual earnings before interest & taxes has changed by +$8.89 M (+47.97%)
What is Cyclerion Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CYCN is -$1.13 M
What is the all time high quarterly EBIT for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly earnings before interest & taxes is -$1.13 M
What is Cyclerion Therapeutics quarterly EBIT year-on-year change?
Over the past year, CYCN quarterly earnings before interest & taxes has changed by +$1.58 M (+58.39%)
What is Cyclerion Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CYCN is -$5.92 M
What is the all time high TTM EBIT for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM earnings before interest & taxes is -$5.92 M
What is Cyclerion Therapeutics TTM EBIT year-on-year change?
Over the past year, CYCN TTM earnings before interest & taxes has changed by +$6.38 M (+51.85%)